NCT06456073 - E-CEL UVEC Treatment for Anal Fissures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Chronic Anal Fissure

Interventions

BIOLOGICAL

E-CEL UVEC cells (AB-207)

Allogeneic (consented-maternal donor) E4ORF1+ (pro-survival gene transduced) human umbilical vein endothelial cells (percutaneous injection formulation)

Trial Locations (1)

10065

RECRUITING

Weill Cornell Medicine, New York